Search

Your search keyword '"M. Schmauß"' showing total 79 results
Start Over Author "M. Schmauß" Database OpenAIRE
79 results on '"M. Schmauß"'

1. ECMO als Therapie des schweren Lungenversagens bei COVID-19

Author

E. Müller, Santiago Ewig, C. Giesa, M. Schwamborn, and M. Schmauss

Subjects
Pulmonary and Respiratory Medicine, Gynecology, medicine.medical_specialty, 2019-20 coronavirus outbreak, biology, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Treatment outcome, biology.organism_classification, medicine.disease_cause, medicine, business, Betacoronavirus, Coronavirus
Abstract

ZusammenfassungWir berichten über den Fall einer 60-jährigen Patientin mit fortgeschrittenem schwerem Lungenversagen bei COVID-19-assoziierter Pneumonie. Die Patientin erhielt zuerst 2 Tage eine (Highflow-)Sauerstoff-Therapie (HFNC) und CPAP, anschließend musste sie intubiert und invasiv beatmet werden. Nach dem Scheitern einer invasiven Beatmung mit schwerster Hypoxämie erfolgte der Anschluss an eine vv-ECMO. Diese wurde über 24 Tage durchgeführt. Die prognostischen Parameter zeigten ab Tag 14 eine günstige Tendenz. Nach Beendigung der ECMO und insgesamt 11 Tagen stundenweiser assistierter Beatmung über Tracheostoma und Sauerstoff (1 l/min) konnte die Patientin in die Rehabilitationsbehandlung verlegt werden. Die letzte Röntgenthoraxaufnahme zeigte eine nahezu vollständige Rückbildung der initialen ausgedehnten beidseitigen Verschattungen. Unser Fall zeigt, dass auch nach einer prolongierten ECMO-Therapie eine Ausheilung der schweren COVID-assoziierten Lungenschäden möglich ist.

Published
2020
Full Text
View/download PDF

2. [ECMO Therapy in a Case of Severe ARDS Related to COVID-19]

Author

M, Schmauss, E, Müller, M, Schwamborn, C, Giesa, and S, Ewig

Subjects
Respiratory Distress Syndrome, SARS-CoV-2, Pneumonia, Viral, COVID-19, Middle Aged, Coronavirus, Betacoronavirus, Extracorporeal Membrane Oxygenation, Treatment Outcome, Humans, Female, Coronavirus Infections, Respiratory Insufficiency, Lung, Pandemics
Abstract

We report the case of a 60-year old female patient with advanced severe lung injury as a consequence of COVID-19-pneumonia. The patient was initially treated with highflow oxygen via nasal cannula (HFNC) and CPAP for two days but had to be intubated and mechanically ventilated. After failure of mechanical ventilation because of persistant severe hypoxemia treatment was switched to ECMO which was applicated for 24 days. Prognostic parameters indicated a favourable trend after day 14. After discontinuation of ECMO and 11 days of intermittent assisted ventilation via tracheostoma and low dose oxygen (1 l/min), the patient could be transferred to rehabilitation. The last chest radiograph prior to transferral revealed a nearly complete resolution of bilateral pulmonary infiltrates. Our case demonstrates that severe COVID-19-associated lung injury can be reversible even after prolonged ECMO.Wir berichten über den Fall einer 60-jährigen Patientin mit fortgeschrittenem schwerem Lungenversagen bei COVID-19-assoziierter Pneumonie. Die Patientin erhielt zuerst 2 Tage eine (Highflow-)Sauerstoff-Therapie (HFNC) und CPAP, anschließend musste sie intubiert und invasiv beatmet werden. Nach dem Scheitern einer invasiven Beatmung mit schwerster Hypoxämie erfolgte der Anschluss an eine vv-ECMO. Diese wurde über 24 Tage durchgeführt. Die prognostischen Parameter zeigten ab Tag 14 eine günstige Tendenz. Nach Beendigung der ECMO und insgesamt 11 Tagen stundenweiser assistierter Beatmung über Tracheostoma und Sauerstoff (1 l/min) konnte die Patientin in die Rehabilitationsbehandlung verlegt werden. Die letzte Röntgenthoraxaufnahme zeigte eine nahezu vollständige Rückbildung der initialen ausgedehnten beidseitigen Verschattungen. Unser Fall zeigt, dass auch nach einer prolongierten ECMO-Therapie eine Ausheilung der schweren COVID-assoziierten Lungenschäden möglich ist.

Published
2020

3. Lipidome analysis in individuals with schizophrenia reveals characteristic plasma lipid profiles

Author

E.C. Schulte, A. Tkachev, E. Stekolshchikova, A. Vanyushkina, H. Zhang, A. Morozova, S. Zozulya, I. Kurochkin, N. Anikanov, A. Egorova, E. Yushina, T. Vogl, F. Senner, S.K. Schaupp, D. Reich-Erkelenz, S. Papiol, M. Oraki Kohshour, F. Klöhn-Saghatolislam, J.L. Kalman, U. Heilbronner, M. Heilbronner, K. Gade, A.L. Comes, M. Budde, H. Anderson-Schmidt, K. Adorjan, J. Wiltfang, E. Reininghaus, G. Juckel, U. Dannlowski, A. Fallgatter, C. Spitzer, M. Schmauß, M. von Hagen, Y. Zorkina, A. Reznik, A. Barkhatova, R. Lisov, N. Mokrov, M. Panov, D. Zubkov, D. Petrova, C. Zhou, Y. Liu, J. Pu, G. Kostyuk, T. Klyushnik, P. Falkai, P. Xie, P. Khaitovich, and T.G. Schulze

Published
2022
Full Text
View/download PDF

4. Diagnostik und Differenzialdiagnosen depressiver Störungen

Author

M. Schmauß

Subjects
Gynecology, medicine.medical_specialty, business.industry, medicine, Neurology (clinical), Family Practice, business
Abstract

ZusammenfassungDepressive Störungen sind in den aktuellen Diagnosesystemen ICD-10 und DSM-IV bzw. DSM-V primär nach klinischen Kriterien wie Schweregrad und Verlauf eingeteilt. Neben dieser kategorealen Diagnostik werden in diesem Artikel auch Aspekte der syndromalen Diagnostik dargestellt. Im Weiteren finden sich Hinweise auf das diagnostische Vorgehen bei Verdacht auf depressive Störungen und auf die wichtigsten somatischen und psychiatrischen Differenzialdiagnosen (Angsterkrankungen, Belastungsstörungen, schizoaffektive Psychosen, Schizophrenie, Burnout).

Published
2015
Full Text
View/download PDF

6. Escitalopram in Clinical Practice: Results of an Open-Label Trial in Outpatients with Depression in a Naturalistic Setting in Germany

Author

S. Langer, Hans-Jürgen Möller, and M. Schmauß

Subjects
Adult, Male, medicine.medical_specialty, Nausea, Citalopram, Behavior Therapy, Rating scale, Germany, Internal medicine, mental disorders, medicine, Humans, Escitalopram, Pharmacology (medical), Psychiatry, Depression (differential diagnoses), Aged, Depressive Disorder, Dose-Response Relationship, Drug, General Medicine, Middle Aged, medicine.disease, Psychiatry and Mental health, Socioeconomic Factors, Tolerability, Antidepressive Agents, Second-Generation, Major depressive disorder, Female, Observational study, medicine.symptom, Psychology, Phytotherapy, medicine.drug
Abstract

∇ Introduction: An open, multi-center, study was designed to address the efficacy and tolerability profile of treatment with escitalopram under naturalistic conditions in outpatients with depression. Methods: A total of 11,760 patients were treated with escitalopram and followed for 8 weeks. Rating scales included the Clinical Global Impression-Severity (CGI-S), the Clinical Global Impression-Improvement (CGI-I), and a short version of the Montgomery-Asberg Depression Rating Scale (svMADRS) for assessment of various clinical parameters. Results: During the course of the study, patients showed a clear pattern of improvement in their general state of health (CGI-S) and a decrease in the severity of their depression. The majority (82.8%) of patients initially received 10mg/day escitalopram. By the end of the trial period, 32.5% of the patients were treated with 20mg/ day escitalopram compared to 64.0% receiving 10mg/day escitalopram. After 2 weeks, 40.7% of patients were much or very much improved (CGI-I ≤2), increasing to 82.5% at the last assessment. There were no significant differences in response to treatment between women and men, with regard to treatment by specialists versus GPs, or with regard to age (≤ 65 versus >65 years of age). Adverse reactions were similar to those found in controlled trials, and no new reactions were noted. The most common adverse reactions were nausea, anxiety, and vertigo. Conclusions: This observational study corroborates the high therapeutic efficacy of escitalopram treatment, while confirming the tolerability profile, in a naturalistic treatment setting.

Published
2007
Full Text
View/download PDF

8. Mitteilungen der DGPPN 3/06

Author

M Schmauss, H Fleischmann, Helmfried E. Klein, I Senft, Albert Putzhammer, Wolfgang Schreiber, and Goeran Hajak

Subjects
medicine.medical_specialty, business.industry, Everyday activities, Context (language use), Therapeutic work, General Medicine, Psychiatry and Mental health, Economic situation, Documentation, Neurology, Work (electrical), Intervention (counseling), Workforce, medicine, Neurology (clinical), Psychiatry, business
Abstract

In Germany, the economic situation of psychiatric hospitals has markedly changed during the last years. Whilst the number of patients has steadily increased, many clinics considerably reduced the number of therapeutic staff due to an increasing lack of financial support. The German psychiatry personnel regulations act defines the number of therapeutic staff required for an adequate psychiatric treatment, but the requirements of this regulations act nowadays are widely missed in most of the German psychiatric hospitals. This severely affects the therapeutic work on psychiatric wards. This study analyses tasks and activities of medical doctors on psychiatric wards and compares the hours spent with various types of activities with the amount of time that should be spent according to the personnel regulations act. Results show that doctors spend much more time with documentation and administrative work than originally intended by the personnel regulations act. They compensate this mainly by a reduction of time spent in direct contact with the patients. In this context, the number of psychotherapy sessions as well as sessions with the patients' relatives has been considerably reduced, whereas the time spent for emergency intervention and basic treatment still corresponds to the calculations according to the personnel regulations act. All in all, the results show that a reduction of therapeutic staff in psychiatric hospitals directly leads to a change in treatment settings with a focus on less individual treatment options.

Published
2006
Full Text
View/download PDF

9. Dysthymia

Author

M, Schmauss and T, Messer

Subjects
Diagnosis, Differential, Psychotherapy, Psychiatry and Mental health, Neurology, Behavior Therapy, Humans, Neurology (clinical), Dysthymic Disorder, Long-Term Care, Antidepressive Agents
Published
2005
Full Text
View/download PDF

11. Off-Label-Use in der Psychopharmakotherapie

Author

M. Schmauß and J. Fritze

Subjects
Psychiatry and Mental health, medicine.medical_specialty, Psychotherapist, Neurology, business.industry, Medicine, Psychosomatic medicine, Neurology (clinical), General Medicine, business, Off-label use
Published
2002
Full Text
View/download PDF

12. Agitation und Aggression in der Psychiatrie

Author

F.-G. Pajonk and M. Schmauß

Subjects
Psychiatry and Mental health, medicine.medical_specialty, Neurology, Psychomotor agitation, Aggression, medicine, Neurology (clinical), medicine.symptom, Psychiatry, Psychology
Published
2015
Full Text
View/download PDF

13. [Drug safety in clinical practice--part 2: psychopharmacological treatment]

Author

S, Stübner, R, Grohmann, and M, Schmauß

Subjects
Psychiatry, Psychopharmacology, Communication, Mental Disorders, Pharmacoepidemiology, Forensic Psychiatry, History, 20th Century, History, 21st Century, Risk Assessment, Pharmacovigilance, Research Design, Humans, Patient Compliance, Patient Safety
Published
2013

14. Kombinationstherapien bei Therapieresistenz auf Antidepressiva - eine Übersicht

Author

A Erfurth and M Schmauss

Subjects
Lithium (medication), Fenfluramine, business.industry, Pharmacology, Placebo, Buspirone, Psychiatry and Mental health, Clinical research, Pharmacotherapy, Neurology, Refractory, medicine, Antidepressant, Neurology (clinical), business, medicine.drug
Abstract

Despite the availability of a wide range of effective antidepressant drugs, nearly 30% of depressed patients fail to respond to antidepressant treatment. Various pharmacological strategies have been developed to treat such refractory depression, of which augmentation therapies are one of the most important. This article reviews both benefits and risks of all known augmentation therapies. Among these treatment strategies the efficacy of lithium augmentation is very well documented by a large number of controlled studies - lithium augmentation can therefore be recommended in depression refractory to antidepressant treatment. The efficacy of triiodothyronine (T3) augmentation and the combination of different antidepressants - like a TCA-MAOI combination - is described in a large number of case reports and uncontrolled studies; the number of placebo controlled double blind studies, confirming the efficacy of these treatment strategies, is however relatively small. T3 augmentation and combined antidepressant treatment may therefore be considered in the treatment of refractory depression; in contrast to lithium augmentation these combination therapies are however only second-line strategies. Other augmentation therapies (TCA + stimulants, TCA + reserpine, TCA + yohimbine, TCA + fenfluramine, SSRI + buspirone) are very interesting clinical research strategies, but don't have too much importance in clinical practice at the moment.

Published
1996
Full Text
View/download PDF

16. [Drug safety in clinical practice--part 1: psychopharmacological treatment]

Author

S, Stübner, R, Grohmann, and M, Schmauß

Subjects
Psychotropic Drugs, Drug-Related Side Effects and Adverse Reactions, Psychopharmacology, Mental Disorders, Humans, Patient Compliance, Drug Interactions, Drug Therapy, Combination, Pharmacokinetics, Patient Safety, Drug Monitoring, Long-Term Care
Published
2012

17. Valproinsäure als Phasenprophylaktikum

Author

K.G. Rottach, M Schmauss, U. Wieland, and J. Weiss-Brummer

Subjects
Valproic Acid, Pediatrics, medicine.medical_specialty, Risperidone, business.industry, medicine.medical_treatment, Encephalopathy, General Medicine, medicine.disease, Psychiatry and Mental health, Epilepsy, Anticonvulsant, Neurology, medicine, Neurology (clinical), Bipolar disorder, Epileptic seizure, medicine.symptom, business, medicine.drug, Asterixis
Abstract

A 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene. The clinical signs were drowsiness, ataxic gait, asterixis, and a generalized epileptic seizure. Discontinuation of valproic acid gradually resulted in complete remission of these symptoms. Valproate encephalopathy has been described mainly in patients receiving anticonvulsant polytherapy. This complication might become more prevalent in psychiatric pharmacotherapy due to the increasing use of valproic acid.

Published
2000
Full Text
View/download PDF

18. [Treatment-resistant depression]

Author

M, Schmauss and T, Messer

Subjects
Depressive Disorder, Drug Resistance, Lithium Compounds, Humans, Triiodothyronine, Electric Stimulation Therapy, Estrogens, Phototherapy, Combined Modality Therapy, Transcranial Magnetic Stimulation, Antidepressive Agents, Antipsychotic Agents
Published
2009

20. [Treatment of bipolar disorders]

Author

M, Schmauss and T, Messer

Subjects
Bipolar Disorder, Dose-Response Relationship, Drug, Lithium Carbonate, Antimanic Agents, Humans, Anticonvulsants, Drug Therapy, Combination, Drug Monitoring, Antipsychotic Agents
Published
2009

21. [Combining antidepressants: a useful strategy for therapy resistant depression?]

Author

M, Schmauss and T, Messer

Subjects
Depressive Disorder, Monoamine Oxidase Inhibitors, Drug Resistance, Humans, Drug Therapy, Combination, Antidepressive Agents, Tricyclic, Antidepressive Agents, Selective Serotonin Reuptake Inhibitors
Abstract

Various pharmacological strategies have been developed to treat such refractory depression, of which combination therapies with antidepressants are one of the most important. This article reviews both benefits and risks of all known antidepressant combination strategies. The relevant literature was identified by means of a computerized MEDLINE research on the years 1990-2006 and scanning of review articles. The use of antidepressant combinations to overcome refractory depression is a common strategy in practice. Many antidepressants can be usefully combined especially if they engage separate mechanisms of action--like SSRIs with Reboxetine, Bupropion, Mirtazapine and Tricyclics--or on the other hand--Tricyclics with MAO-Inhibitiors. Combination strategies are effective treatment options, however they do have potential safety risks due to pharmacokinetic and pharmacodynamic interactions. Combinations including MAOIs can cause serotonin syndrome, and some SSRIs like Fluoxetine may elevate tricyclic plasma levels with the consequence of an increased risk of toxicity. The distinct knowledge of available antidepressant combination strategies may help to increase response--as well as remission rates in therapy resistant depression. However, further research is urgently needed to determine relative efficacy.

Published
2009

23. Adenosin und Methylxanthine im Zentralnervensystem - zur Bedeutung für Psychiatrie und Neurologie

Author

M Schmauss and Andreas Erfurth

Subjects
medicine.medical_specialty, Neurology, business.industry, Central nervous system, Dopaminergic, Carbamazepine, Adenosinergic, Adenosine receptor, Adenosine, Psychiatry and Mental health, medicine.anatomical_structure, medicine, Neurology (clinical), business, Psychiatry, Receptor, Neuroscience, medicine.drug
Abstract

In the last 15 years the central effects of adenosine and its importance for neurology and psychiatry have increasingly become an object of investigation. Physiology and metabolism of adenosine have been examined by different research groups. The effects of adenosine in the central nervous system and the various mechanisms of these effects have been described by electrophysiologic methods. The inhibition of the release of several neurotransmitters through adenosine has already been described 10 years ago. In this review studies on binding sites for adenosine receptor ligands are discussed thoroughly. The properties and the highly specific distribution of the distinct receptor subtypes are described. For the functioning of the adenosinergic system the different interactions with other centrally active substances such as benzodiazepines, barbiturates, neuroleptics, anti-depressants, opiates, alcohol and carbamazepine have turned out to be of interest. The results of neuropsychiatric investigations on methylxanthines, which are antagonists at the adenosine receptor, are widely considered. Finally the discussion on the importance of the adenosinergic system in different neurological and psychiatric diseases is summed up. The particular significance of adenosine in the modulation of dopaminergic functions is emphasised.

Published
1990
Full Text
View/download PDF

24. [Biological treatment of acute depressive episodes]

Author

M, Schmauss and T, Messer

Subjects
Affective Disorders, Psychotic, Depressive Disorder, Bipolar Disorder, Acute Disease, Humans, Electroconvulsive Therapy, Antidepressive Agents
Published
2007

25. [Polypharmacy in the treatment of schizophrenia]

Author

T, Messer, C, Tiltscher, and M, Schmauss

Subjects
Hospitalization, Antimanic Agents, Schizophrenia, Humans, Drug Therapy, Combination, Antidepressive Agents, Antipsychotic Agents
Abstract

Current standards for the pharmacological treatment of schizophrenia favour antipsychotic monotherapy. Most atypical antipsychotics developed in recent years meet the statutory requirement of being at least as effective as Haloperidol. Nevertheless, pharmacoepidemiological data show an increase in polypharmacy. The importance of the studies is underlined by the fact that 40 - 50 % of schizophrenic inpatients and up to 90 % schizophrenic outpatients receive antipsychotic combination therapies. Treatment resistance, reduction of dose-related side effects caused by antipsychotic monotherapy or the effect on concomitant symptoms of schizophrenia, such as comorbid depression, might justify combination therapy or augmentation strategies. Apart from the high costs, polypharmacy is associated with reduced patient compliance and an increased risk of undesired pharmacological effects. Since polypharmacy is increasingly common further educational measures in psychopharmacology should be getting more attention. Due to the very small number of controlled studies that exist at present this report will focus on case reports of the most frequent as well as some of the lesser prescribed combination therapies. Finally, conclusions will be discussed in relation to therapy recommendations.

Published
2006

31. [Off-label use: the case of methylphenidate (Ritalin)]

Author

J, Fritze and M, Schmauss

Subjects
Adult, Drug Utilization Review, Attention Deficit Disorder with Hyperactivity, Substance-Related Disorders, Germany, Methylphenidate, Humans, Central Nervous System Stimulants, Drug Utilization, Drug Labeling
Published
2003

32. Mehr Lebensqualität mit modernen Antipsychotika

Author

M. Schmauss

Abstract

Obwohl moderne Antipsychotika wirksam und im Unterschied zu herkommlichen Neuroleptika besser vertraglich sind, werden sie in Deutschland und Europa nur bei etwa einem Drittel der Schizophreniepatienten verordnet. Eine europaische Umfrage unter Psychiatern und Patienten untersuchte die Grunde [1].

Published
2003
Full Text
View/download PDF

33. Schizophrenie — Therapeutische Möglichkeiten 'State of the Art' und 'Unmet Needs'

Author

T. Messer and M. Schmauss

Subjects
Gynecology, medicine.medical_specialty, Political science, medicine, Unmet needs
Abstract

Mit einer Lebenszeitpravalenz von 0,5–1 % (Hafher 1989) stellt die Schizophrenie immer noch eine Herausforderung fur jedes Gesundheitssystem dar. Die Erstmanifestation einer Schizophrenie ereignet sich meist im fruhen Erwachsenenalter und stellt einen gravierenden Einschnitt in der personlichen, beruflichen und sozialen Entwicklung eines Betroffenen dar.

Published
2003
Full Text
View/download PDF

34. [Off-label use in psychopharmacotherapy]

Author

J, Fritze and M, Schmauss

Subjects
Clinical Trials as Topic, National Health Programs, Therapeutic Equivalency, Psychopharmacology, Germany, Humans, Drug Approval, Drug Costs
Published
2002

41. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy]

Author

K G, Rottach, J, Weiss-Brummer, U, Wieland, and M, Schmauss

Subjects
Adult, Male, Bipolar Disorder, Dyskinesias, Treatment Outcome, Antimanic Agents, Brain Diseases, Metabolic, Valproic Acid, Remission Induction, Humans, Ataxia, Epilepsy, Generalized, Sleep Stages
Abstract

A 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene. The clinical signs were drowsiness, ataxic gait, asterixis, and a generalized epileptic seizure. Discontinuation of valproic acid gradually resulted in complete remission of these symptoms. Valproate encephalopathy has been described mainly in patients receiving anticonvulsant polytherapy. This complication might become more prevalent in psychiatric pharmacotherapy due to the increasing use of valproic acid.

Published
2000

42. Psychopharmakotherapie bei Erkrankungen des Zentralnervensystems

Author

M. Schmauss, H. J. Möller, and M. Bergener

Abstract

In den vergangenen Jahrzehnten haben in Europa v.a. altersassoziierte Erkrankungen zugenommen, da der Anteil alterer Menschen an der Gesamtbevolkerung nicht nur kontinuierlich, sondern sogar exponentiell ansteigt. Zu den in der Haufigkeit zunehmenden Erkrankungen sind v.a. Neoplasien, kardiovaskulare Erkrankungen sowie psychiatrische Storungen zu zahlen. Hier mus neben depressiven und paranoiden Storungen sowie den Angst-und Abhangigkeitserkrankungen im Alter ein besonderes Augenmerk auf die dementiellen Erkrankungen gerichtet werden. Die Pravalenzraten in der Altersgruppe der uber 65jahrigen liegen z. B. fur die depressiven Syndrome bei 20–25% und fur die dementiellen Syndrome bei 5–10%, wobei die haufigste Demenzform in dieser Altersgruppe, die Alzheimer-Demenz, mit zunehmendem Alter einen exponentiellen Anstieg der Pravalenzraten aufweist. Sind in der Altersgruppe der 65- bis 70jahrigen nur 2–3% betroffen, so erkranken in der Altersgruppe der 80- bis 89jahrigen bereits 20%, in der Altersgruppe der uber 90jahrigen sogar mehr als 30% (Hafner 1990). Ergebnisse verschiedener Bevolkerungsvorausberechnungen prognostizieren fur das Jahr 2030 eine weitere Erhohung des Anteils alterer Menschen an der Gesamtbevolkerung, der dann ca. 20–30% bei den uber 65jahrigen betragen wird. Erkrankungen im hoheren Lebensalter fuhren haufig zu erheblichen Kosten fur den Patienten und seine Angehorigen.

Published
2000
Full Text
View/download PDF

43. Strukturen, Abläufe und Maßnahmen zur optimalen Versorgung schizophrener Patienten im Psychiatrischen Krankenhaus

Author

M. Schmauss

Abstract

Alle Behandlungsschritte in der Versorgung schizophren Kranker sind — wie auch sonst in der psychiatrischen Therapie — in einen Gesamtbehandlungsplan zu integrieren sowie individuell und phasenspezifisch abzustimmen. Im Verlauf der Schizophrenie konnen verschiedene Krankheitsphasen und Verlaufsstadien mit unterschiedlichen therapeutischen Schwerpunkten unterschieden werden. Im psychiatrischen Krankenhaus werden primar Patienten in der akuten Phase sowie in der postakuten Stabilisierungsphase einer Schizophrenie behandelt. Die Behandlung der Schizophrenie im stationaren Bereich benotigt eine differenzierte Diagnostik und besteht aus einer Reihe von Komponenten, die sich gegenseitig bedingen und unterstutzen, um die therapeutischen Schwerpunkte der akuten und postakuten Behandlungsphase sicherzustellen.

Published
2000
Full Text
View/download PDF

44. CME – Wohin geht’s 2009?

Author

P Berlit, M Weih, and M Schmauss

Subjects
Psychiatry and Mental health, Medical education, Neurology, Continuing medical education, business.industry, Medicine, Neurology (clinical), business
Published
2009
Full Text
View/download PDF

45. D

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

46. A

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

47. H

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

48. I

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

49. C

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

50. G

Author

Franz von Bruchhausen, Eberhard Hackenthal, Siegfried Ebel, Ulrike Holzgrabe, August Wilhelm Frahm, M. Albinus, G. Amschler, E. von Angerer, null Arras-Reiter, P. Barth, W. Barthel, K. Bauer, P. Bauer, I. Baumann, J. Beckmann, W. Beil, J. Reitz, K. Binder, F. Bossle, F. Bracher, H. Bräunlich, E. Bretschneider, R. Brigelius-Flohé, K. Brinkmann, F. von Bruchhausen, A. Rüge, W. Christ, M. Cimbollek, R. Daniels, G. Dannhardt, H. Duchstein, S. Ebel, K. Eger, P. Eichhorn, U. Eiben, T. Erker, P. Felfe, A. Frahm, M. Frahm, V. Franke, K. Freundt, D. Geffken, U. Geis, E. Glusa, B. Göber, P. Gobina, W. Golder, M. Goppelt­Strübe, K. Götte, E. Gottstein, G. Greif, A. Grisk, M. Grosam, H. Gustmann, M. Gütschow, E. Hackenthal, A. Häfner, B. Haluszczynski, A. Harder, H. Häusler, D. Heber, M. Heidenreich, G. Heinemeyer, E. Heller, D. von Herrath, J. Hilfenhaus, H. Hoffmann, U. Hoffmann-Schollmayer, B. Hofmann, C. Holpert, U. Holzgrabe, U. Hübner-Steiner, M. Hug, E. Inkmann, A. Jördens, J. Jürgens, B. Kaiser, D. Kalbhen, H. Kemmler, P. Kisser, D. Kleinsorge, C. Klett, S. Klett, M. Klingmüller, H. Klöcking, A. Kramer, B. Krammer, M. Kreher, M. Krüger, M. Kuhn, D. Landsiedel-Maier, P. Lauven, J. Lehmann, M. Lehner, D. Leopoldt, A. Maurer, W. Meindl, K. Menges, P. Mes­singer, F. Meyer, W. Meyerhof, R. Morgenstern, U. Mühlhans, A. Müller, C. Müller, K. Müller, A. Mülsch, C. Nachtsheim, M. Neugebauer, W. Neupert, P. Nickel, P. Nuhn, B. Nürnberg, H. Oelschläger, J. Oertel, M. Oettel, R. Ott, T. Ott, T. Otzen, P. Pachaly, H. Pelzer, K. Petersen, R. Pick, M. Pickert, A. Pies, H. Priewer, O. Queckenberg, G. Radau, E. Reimann, J. Remien, M. Reuß, W. Reuß, J. Richter, P. Richter, K. Riecke, H. Rommelspacher, U. Rose, G. Roth, D. Rothley, G. Rücker, J. Schäfer, J. Schantl, H. Schlager, H. Schleinitz, W. Schlichter, M. Schmauß, H. Schmidhammer, G. Schmidt, T. Schmidt, H. Schmitt, J. Sehräder, T. Schulz, H. Schwilden, M. Serke, G. Skopp, G. Skorka, K. Smolinka, U. Speck, M. Spohn, R. Stahlmann, J. Stasch, C. Steffen, H. Stein, J. Steinmeyer, K. Stiefvater, G. Strippel, K. Surborg, U. Stürig, H. Szelényi, I. Szelényi, A. Täufel, R. Thieroff-Ekerdt, R. Troschütz, H. Ungeheuer, B. Unterhalt, E. Verspohl, S. Vogel, F. Volk, T. Vorwerk, J. Wallmann, H. Weber, M. Wenzel, M. Weyandt-Spangenberg, S. Wich, R. Wintersteiger, B. Wüst, and D. Youssef

Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results